Memo Therapeutics closed a Series B financing round of CHF37 million.

Biotech Health services Manufacturing

Investments

14 February 2022

Memo Therapeutics (company)

Biotech Health services Manufacturing

Total investments received (USD): 112.24m

Round value (USD): 40.06m

Round investors: Adjuvant Capital Verve Ventures Swisscanto Invest Vesalius Biocapital Partners Zürcher Kantonalbank Fresenius Medical Care Ventures GF Group

Industry: Biotech Health services Manufacturing

Biotech Health services

Investments 02 August 2022

Biotech Competitive Intelligence Health services Pharma Software Services

Investments 30 March 2022

Health services Manufacturing

Investments 11 February 2022

Biotech Health services Pharma

Investments 04 November 2021